Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression

Metabolism: Clinical and Experimental

Volumn 69, Issue , 2017, Pages 1-13

  Singh, Ruma G ^a   Yoon, Harry D ^a   Wu, Landy M ^a   Lu, Jun ^b   Plank, Lindsay D ^a   Petrov, Maxim S ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

Author keywords

Diabetes mellitus; Ectopic fat; Metabolic disorders; Non alcoholic fatty pancreas disease

Indexed keywords

AGE; COMORBIDITY; DATA BASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ECTOPIC FAT ACCUMULATION; HUMAN; HYPERTENSION; LIPID STORAGE; META ANALYSIS; METABOLIC SYNDROME X; NON ALCOHOLIC FATTY PANCREAS DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PANCREAS DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW; ANIMAL; COMPLICATION; GENETICS; LIPID METABOLISM; METABOLIC DISEASES; METABOLISM; PANCREATIC DISEASES; PATHOLOGY;

FAT;

ANIMALS; FATS; HUMANS; LIPID METABOLISM; METABOLIC DISEASES; PANCREAS; PANCREATIC DISEASES; PREVALENCE;

EID: 85008477482     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2016.12.012     Document Type: Review

References (50)

1. [1] Wree, A., Broderick, L., Canbay, A., Hoffman, H.M., Feldstein, A.E., From NAFLD to NASH to cirrhosis—new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol 10 (2013), 627–636, 10.1038/nrgastro.2013.149.
2. [2] Vernon, G., Baranova, A., Younossi, Z.M., Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults: Systematic review: epidemiology of NAFLD and NASH. Aliment Pharmacol Ther 34 (2011), 274–285, 10.1111/j.1365-2036.2011.04724.x.
3. [3] Chalasani, N., Younossi, Z., Lavine, J.E., Diehl, A.M., Brunt, E.M., Cusi, K., et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55 (2012), 2005–2023.
4. [4] Rinella, M.E., Nonalcoholic Fatty Liver Disease: A Systematic Review. JAMA 313 (2015), 2263–2273, 10.1001/jama.2015.5370.
5. [5] Anstee, Q.M., Targher, G., Day, C.P., Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10 (2013), 330–344, 10.1038/nrgastro.2013.41.
6. [6] Smits, M.M., van Geenen, E.J.M., The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol 8 (2011), 169–177, 10.1038/nrgastro.2011.4.
7. [7] American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 37 (2014), S81–S90, 10.2337/dc14-S081.
8. [8] Alberti, K.G.M.M., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120 (2009), 1640–1645, 10.1161/CIRCULATIONAHA.109.192644.
9. [9] Expert Panel on Metabolic Syndrome of Chinese Diabetes Society, Recommendations on metabolic syndrome of Chinese Diabetes Society (Chinese). Chin J Diabetes 12 (2004), 156–161.
10. [10] Saverymuttu, S.H., Joseph, A.E., Maxwell, J.D., Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 292 (1986), 13–15.
11. [11] Browning, J.D., Szczepaniak, L.S., Dobbins, R., Nuremberg, P., Horton, J.D., Cohen, J.C., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology (Baltimore Md) 40 (2004), 1387–1395, 10.1002/hep.20466.
12. [12] Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003), 2560–2572, 10.1001/jama.289.19.2560.
13. [13] DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
14. [14] Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994), 1088–1101.
15. [15] Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997), 629–634.
16. [16] Harbord, R.M., Egger, M., Sterne, J.A.C., A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25 (2006), 3443–3457, 10.1002/sim.2380.
17. [17] Knapp, G., Hartung, J., Improved tests for a random effects meta-regression with a single covariate. Stat Med 22 (2003), 2693–2710, 10.1002/sim.1482.
18. [18] Tushuizen, M.E., Bunck, M.C., Pouwels, P.J., Bontemps, S., van Waesberghe, J.H.T., Schindhelm, R.K., et al. Pancreatic fat content and -cell function in men with and without type 2 diabetes. Diabetes Care 30 (2007), 2916–2921, 10.2337/dc07-0326.
19. [19] Lingvay, I., Esser, V., Legendre, J.L., Price, A.L., Wertz, K.M., Adams-Huet, B., et al. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 94 (2009), 4070–4076, 10.1210/jc.2009-0584.
20. [20] Heni, M., Machann, J., Staiger, H., Schwenzer, N.F., Peter, A., Schick, F., et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 26 (2010), 200–205, 10.1002/dmrr.1073.
21. [21] van der Zijl, N.J., Goossens, G.H., Moors, C.C.M., van Raalte, D.H., Muskiet, M.H.A., Pouwels, P.J.W., et al. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab 96 (2011), 459–467, 10.1210/jc.2010-1722.
22. [22] Rossi, A.P., Fantin, F., Zamboni, G.A., Mazzali, G., Rinaldi, C.A., Del Giglio, M., et al. Predictors of ectopic fat accumulation in liver and pancreas in obese men and women. Obesity 19 (2011), 1747–1754, 10.1038/oby.2011.114.
23. [23] Li, J., Xie, Y., Yuan, F., Song, B., Tang, C., Noninvasive quantification of pancreatic fat in healthy male population using chemical shift magnetic resonance imaging: effect of aging on pancreatic fat content. Pancreas 40 (2011), 295–299.
24. [24] Maggio, A.B., Mueller, P., Wacker, J., Viallon, M., Belli, D.C., Beghetti, M., et al. Increased pancreatic fat fraction is present in obese adolescents with metabolic syndrome. J Pediatr Gastroenterol Nutr 54 (2012), 720–726.
25. [25] Patel, N.S., Peterson, M.R., Lin, G.Y., Feldstein, A., Schnabl, B., Bettencourt, R., et al. Insulin resistance increases MRI-estimated pancreatic fat in nonalcoholic fatty liver disease and normal controls. Gastroenterol Res Pract 2013 (2013), 1–8, 10.1155/2013/498296.
26. [26] Lim, S., Bae, J.H., Chun, E.J., Kim, H., Kim, S.Y., Kim, K.M., et al. Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetes. Acta Diabetol 51 (2014), 739–748, 10.1007/s00592-014-0581-3.
27. [27] Ma, J., Song, Z., Yan, F., Detection of hepatic and pancreatic fat infiltration in type II diabetes mellitus patients with IDEAL-Quant using 3.0 T MR: comparison with single-voxel proton spectroscopy. Chin Med J (Engl) 127 (2014), 3548–3552.
28. [28] Begovatz, P., Koliaki, C., Weber, K., Strassburger, K., Nowotny, B., Nowotny, P., et al. Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans. Diabetologia 58 (2015), 1646–1655, 10.1007/s00125-015-3544-5.
29. [29] Gaborit, B., Abdesselam, I., Kober, F., Jacquier, A., Ronsin, O., Emungania, O., et al. Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss. Int J Obes (Lond) 39 (2015), 480–487, 10.1038/ijo.2014.126.
30. [30] Kühn, J.-P., Berthold, F., Mayerle, J., Völzke, H., Reeder, S.B., Rathmann, W., et al. Pancreatic steatosis demonstrated at MR imaging in the general population: clinical relevance. Radiology 276 (2015), 129–136.
31. [31] Lee, J.S., Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 15 (2009), 1869–1875, 10.3748/wjg.15.1869.
32. [32] Choi, C.W., Associated factors for a hyperechogenic pancreas on endoscopic ultrasound. World J Gastroenterol 16 (2010), 4329–4334, 10.3748/wjg.v16.i34.4329.
33. [33] Sepe, P.S., Ohri, A., Sanaka, S., Berzin, T.M., Sekhon, S., Bennett, G., et al. A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc 73 (2011), 987–993, 10.1016/j.gie.2011.01.015.
34. [34] Wu, W.-C., Wang, C.-Y., Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case–control retrospective study. Cardiovasc Diabetol, 12, 2013, 77.
35. [35] Kim, M.K., Chun, H.J., Park, J.H., Yeo, D.M., Baek, K.-H., Song, K.-H., et al. The association between ectopic fat in the pancreas and subclinical atherosclerosis in type 2 diabetes. Diabetes Res Clin Pract 106 (2014), 590–596, 10.1016/j.diabres.2014.09.005.
36. [36] Uygun, A., Kadayifci, A., Demirci, H., Saglam, M., Sakin, Y.S., Ozturk, K., et al. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. Eur J Intern Med 26 (2015), 37–41, 10.1016/j.ejim.2014.11.007.
37. [37] Wang, C.-Y., Ou, H.-Y., Chen, M.-F., Chang, T.-C., Chang, C.-J., Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. J Am Heart Assoc, 3, 2014, e000297.
38. [38] Della Corte, C., Mosca, A., Majo, F., Lucidi, V., Panera, N., Giglioni, E., et al. Nonalcoholic fatty pancreas disease and nonalcoholic fatty liver disease: more than ectopic fat. Clin Endocrinol (Oxf) 83 (2015), 656–662, 10.1111/cen.12862.
39. [39] Lesmana, C.R.A., Pakasi, L.S., Inggriani, S., Aidawati, M.L., Lesmana, L.A., Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study. BMC Gastroenterol, 15, 2015, 174, 10.1186/s12876-015-0404-1.
40. [40] Zhou, J., Li, M.-L., Zhang, D.-D., Lin, H.-Y., Dai, X.-H., Sun, X.-L., et al. The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population. Pancreatology 16 (2016), 578–583, 10.1016/j.pan.2016.03.008.
41. [41] Wong, V.W.-S., Wong, G.L.-H., Yeung, D.K.-W., Abrigo, J.M., Kong, A.P.-S., Chan, R.S.-M., et al. Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging. Am J Gastroenterol 109 (2014), 589–597.
42. [42] Reeder, S.B., Cruite, I., Hamilton, G., Sirlin, C.B., Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34 (2011), 729–749.
43. [43] Szczepaniak, L.S., Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. AJP Endocrinol Metab 288 (2005), E462–E468, 10.1152/ajpendo.00064.2004.
44. [44] Das, S.L., Kennedy, J.I., Murphy, R., Phillips, A.R., Windsor, J.A., Petrov, M.S., Relationship between the exocrine and endocrine pancreas after acute pancreatitis. World J Gastroenterol 20 (2014), 17196–17205.
45. [45] Steven, S., Hollingsworth, K.G., Small, P.K., Woodcock, S.A., Pucci, A., Aribisala, B., et al. Weight loss decreases excess pancreatic triacylglycerol specifically in type 2 diabetes. Diabetes Care 39 (2016), 158–165, dc150750, 10.2337/dc15–0750.
46. [46] van Geenen, E.-J.M., Smits, M.M., Schreuder, T.C.M.A., van der Peet, D.L., Bloemena, E., Mulder, C.J.J., Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas 39 (2010), 1185–1190, 10.1097/MPA.0b013e3181f6fce2.
47. [47] Petrov, M.S., Abdominal fat: a key player in metabolic acute pancreatitis. Am J Gastroenterol 108 (2013), 140–142.
48. [48] Xiao, A.Y., Tan, M.L., Wu, L.M., Asrani, V.M., Windsor, J.A., Yadav, D., et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol 1 (2016), 45–55.
49. [49] Le, K.-A., Ventura, E.E., Fisher, J.Q., Davis, J.N., Weigensberg, M.J., Punyanitya, M., et al. Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Diabetes Care 34 (2011), 485–490, 10.2337/dc10-0760.
50. [50] Szczepaniak, L.S., Victor, R.G., Mathur, R., Nelson, M.D., Szczepaniak, E.W., Tyer, N., et al. Pancreatic steatosis and its relationship to β-cell dysfunction in humans: racial and ethnic variations. Diabetes Care 35 (2012), 2377–2383, 10.2337/dc12-0701.